NVCR

NovoCure (NVCR)

About NovoCure (NVCR)

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Details

Daily high

$13.19

Daily low

$12.83

Price at open

$12.94

52 Week High

$34.13

52 Week Low

$10.70

Market cap

1.5B

Dividend yield

0.00%

Volume

1.1M

Avg. volume

1.9M

P/E ratio

-8.05

NovoCure News